Alliance Urology Specialists

Protocol Number: AMGEN 20050103, Sponsor: Amgen, Inc.

	Eligibility Criteria for participation: Males 18 years of age or older with prostate cancer On hormonal therapy A rising PSA No IV bisphosphonates No active dental or jaw condition that requires surgery No prior or current evidence of osteonecrosis/osteomyelitis of the jaw Duration of Study Study period will be 49 weeks during which time you will have weekly clinic visits for administration of study drug. Qualified participants will receive study-related medical exams, laboratory tests, skeletal x-rays and study medication at no cost. Clinical Research Coordinators: Patricia Edwards, RN (336) 274-1114 ext. 5322 Karen Michael, RN (336) 274-1114 ext. 5328 E-mail address: research@allianceurology.com